Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Novo Nordisk A/S banner

Novo Nordisk A/S
XETRA:NOV

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
XETRA:NOV
Watchlist
Price: 38.325 EUR 2.04% Market Closed
Market Cap: €171B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

NOV Price Targets Summary
Novo Nordisk A/S

Wall Street analysts forecast NOV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOV is 43.715 EUR with a low forecast of 26.943 EUR and a high forecast of 63.582 EUR.

NOV Lowest Forecast
26.943 EUR
-30% Downside
NOV Average Forecast
43.715 EUR
14% Upside
NOV Highest Forecast
63.582 EUR
66% Upside
Lowest Forecast
Price Target
26.943 EUR
30% Downside
Average Forecast
Price Target
43.715 EUR
14% Upside
Highest Forecast
Price Target
63.582 EUR
66% Upside
Novo Nordisk A/S Competitors:
Price Targets
C
CPNREIT
CPN Retail Growth Leasehold REIT
0% Downside
PALI
Palisade Bio Inc
480% Upside
C
CPNREIT
CPN Retail Growth Leasehold REIT
0% Downside
PALI
Palisade Bio Inc
480% Upside

Revenue
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for Novo Nordisk A/S

Gross Profit
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Novo Nordisk A/S

Operating Income
Forecast

13% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Novo Nordisk A/S

Pre-Tax Income
Forecast

14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Novo Nordisk A/S

Net Income
Forecast

14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Novo Nordisk A/S

See Also

Summary
NOV intrinsic value, competitors valuation, and company profile.
DCF Valuation
NOV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NOV stock valuation using valuation multiples.
Wall St Estimates
NOV price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NOV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Novo Nordisk A/S listings:
NYSE • USD
NVO
 OTC • USD
NONOF
 XETRA • EUR
NOVC
 F • EUR
NOVA
 F • EUR
NOVC
 LSE • DKK
0QIU
 CSE • DKK
NOVO B
 XBER • EUR
NOV
 F • EUR
NOV
 XBER • EUR
NOVA
 XMUN • EUR
NOV
 XMUN • EUR
NOVA
 SWB • EUR
NOV
 SWB • EUR
NOVA
 DUS • EUR
NOV
 DUS • EUR
NOVA
 XHAM • EUR
NOV
 BMV • MXN
NVON
 LSE • USD
0TDD
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NOV's stock price target?
Price Target
43.715 EUR

According to Wall Street analysts, the average 1-year price target for NOV is 43.715 EUR with a low forecast of 26.943 EUR and a high forecast of 63.582 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join 343,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett